Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 3, 2015, Pages 429-441

  Sharaf, Hana ^a   Matou Nasri, Sabine ^b   Wang, Qiuyu ^a   Rabhan, Zaki ^b   Al Eidi, Hamad ^b   Al Abdulrahman, Abdulkareem ^b   Ahmed, Nessar ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER   (Saudi Arabia)

Author keywords

Advanced glycation endproduct; Breast cancer; Diabetes; Methylglyoxal; Signaling pathway

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; S6 KINASE; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MMP9 PROTEIN, HUMAN; RIBOSOME PROTEIN; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; BOVINE; BREAST NEOPLASMS; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

BOVINAE;

ANIMALS; BREAST NEOPLASMS; CATTLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RIBOSOMAL PROTEINS; UP-REGULATION;

EID: 84919904009     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.12.009     Document Type: Article

References (57)

1. Sparvero L.J., Asafu-Adjei D., Kang R., Tang D., Amin N., Im J., Rutledge R., Lin B., Amoscato A.A., Zeh H.J., Lotze M.T. RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med. 2009, 7:17.
2. Maillard L.C. Action des acides aminés sur les sucres: formation des mélanoïdines par voie méthodique. C. R. Acad. Sci. 1912, 154:66-68.
3. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 2005, 67:3-21.
4. Elosta A., Ghous T., Ahmed N. Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. Curr. Diabetes Rev. 2012, 8:92-108.
5. McCarthy A.D., Cortizo A.M., Giménez-Segura G., Bruzzone L., Etcheverry S.B. Non-enzymatic glycosylation of alkaline phosphatase alters its biological properties. Mol. Cell. Biochem. 1998, 181:63-69.
6. Heilman M., Wellner A., Gadermaier G., Ilchmann A., Briza P., Krause M., Nagai R., Burgdof S., Scheurer S., Vieths S., Henle T., Toda M. Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity. J. Biol. Chem. 2014, 289:7919-7928.
7. Giardino I., Edelstein D., Brownlee M. Non-enzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: a model for intracellular glycosylation in diabetes. J. Clin. Invest. 1994, 94:110-117.
8. Reddy G.K. Cross-linking in collagen by nonenzymatic glycosylation increases the matrix stiffness in rabbit Achilles tendon. Exp. Diabesity Res. 2004, 5:143-153.
9. Poggioli S., Bakala H., Friguet B. Age-related increase of protein glycation in peripheral blood lymphocyte is restricted to preferential target proteins. Exp. Gerontol. 2002, 37:1207-1215.
10. Kilhord B.K., Berg T.J., Birkeland K.I., Thorsby P., Hanssen K.F. Serum levels of advanced glycation endproducts are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 1999, 22:1543-1548.
11. Shuvaev V.V., Laffont I., Serot J.M., Fujii J., Taniguchi N., Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol. Aging 2001, 22:397-402.
12. Sato E., Mori F., Igarashi S., Abiko T., Takeda M., Ishiko S., Yoshida A. Corneal advanced glycation endproducts increase with proliferative diabetic retinopathy. Diabetes Care 2001, 24:479-482.
13. Perkins B.A., Rabbani N., Weston A., Ficociello L.H., Adaikalakoteswari A., Niewczas M., Warram J., Krolewski A.S., Thornally P. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. PLoS ONE 2012, 7:e356551.
14. Abe R., Shimizu T., Sugawara H., Watanabe H., Nakamura H., Choei H., Sasaki N., Yamagishi S., Takeuchi M., Shimizu H. Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions. J. Invest. Dermatol. 2004, 122:461-467.
15. Gangemi S., Allegra A., Aguennouz M., Alonci A., Speciale A., Cannavo A., Cristani M., Russo S., Spatari G., Alibrandi A., Musolino C. Relationship between advanced oxidation protein products, advanced glycation endproducts, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-chronic lymphocytic leukemia. Cancer Investig. 2012, 30:20-26.
16. López-Díez R., Rastrojo A., Villate O., Aguado B. Complex tissue-specific patterns and distribution of multiple RAGE splice variants in different mammals. Genome Biol. Evol. 2013, 5:2420-2435.
17. Shimomoto T., Luo Y., Ohmori H., Chihara Y., Fujii K., Sasahira T., Denda A., Kuniyasu H. Advanced glycation endproducts (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose diet. J. Gastroenterol. 2012, 47:1073-1083.
18. Pichiule P., Chavez J.C., Schmidt A.M., Vannucci S.J. Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation endproducts following hypoxia/ischemia. J. Biol. Chem. 2007, 282:36330-36340.
19. Akirav E.M., Preston-Hurlburt P., Garyu J., Henegariu O., Clynes R., Schmidt A.M., Herold K.C. RAGE expression in human T cells: a line between environmental factors and adaptative immune responses. PLoS ONE 2012, 7:e34698.
20. Li Y., Liu S., Zhang Z., Xu Q., Xie F., Wang J., Ping S., Li C., Wang Z., Zhang M., Huang J., Chen D., Hu L., Li C. RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergic ERK activation. PLoS ONE 2012, 7:e35016.
21. Radia A.M., Yaser A.M., Ma X., Zhang J., Yang C., Dong Q., Rong P., Ye B., Liu S., Wang W. Specific siRNA targeting receptor for advanced glycation endproducts (RAGE) decreases proliferation in human breast cancer cell lines. Int. J. Mol. Sci. 2013, 14:7959-7978.
22. Xie J., Méndez J.D., Méndez-Valenzuela V., Aguilar-Hernández M.M. Cellular signalling of the receptor for advanced glycation endproducts (RAGE). Cell. Signal. 2013, 25:2185-2197.
23. Yoon Y.W., Kang T.S., Lee B.K., Chang W., Huang K.C., Rhee J.H., Min P.K., Hong B.K., Rim S.J., Kwon H.M. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp. Mol. Med. 2008, 40:398-406.
24. Liu C., He J.C., Cai W., Liu H., Zhu L., Vlassara H. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:11767-11772.
25. Huang J.S., Guh J.Y., Chen H.C., Hung W.C., Lai Y.H., Chuang L.Y. Role of advanced glycation endproduct (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J. Cell. Biochem. 2001, 81:102-113.
26. Guimaraes E.L., Empsen C., Geerts A., van Grunsven L.A. Advanced glycation endproducts induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J. Hepatol. 2010, 52:389-397.
27. Kim J.Y., Park H.K., Yoon J.S., Kim S.J., Kim E.S., Ahn K.S., Kim D.S., Yoon S.S., Kim B.K., Lee Y.Y. Advanced glycation endproduct (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways. Int. J. Oncol. 2008, 33:493-501.
28. Klein G., Vellenga E., Fraaije M.W., Kamps W.A., de Bont E.S.J.M. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit. Rev. Oncol. Hematol. 2004, 50:87-100.
29. Riehl A., Németh J., Angel P., Hess J. The receptor RAGE: bridging inflammation and cancer. Cell Commun. Signal. 2009, 7:12.
30. Liao S., Wel W., Wang L., Zhang Y., Li J., Wang C., Sun S. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac. J. Cancer Prev. 2011, 12:1061-1065.
31. Korwar A.M., Bhonsle H.S., Chougale A.D., Kote S.S., Gawai K.R., Ghole V.S., Koppikar C.B., Kulkarni M.J. Analysis of AGE modified proteins and RAGE expression in HER2/neu negative invasive ductal carcinoma. Biochem. Biophys. Res. Commun. 2012, 19:490-494.
32. Tesarová P., Kalousová M., Jáchymová M., Mestek O., Petruzelka L., Zima T. Receptor for advanced glycation endproducts (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Investig. 2007, 25:720-725.
33. Furusyo N., Hayashi J. Glycated albumin and diabetes mellitus. Biochim. Biophys. Acta 2013, 1830:5509-5514.
34. Chung A.C., Zhang H., Kong Y.Z., Tan J.J., Huang X.R., Kopp J.B., Lan H.Y. Advanced glycation endproducts induce tubular CTGF via TGFb-independent Smad3 signaling. J. Am. Soc. Nephrol. 2010, 21:249-260.
35. Ahmed N., Furth A.J. A microassay for protein glycation based on the periodate method. Anal. Biochem. 1991, 192:109-111.
36. Carre A., Lacarriere V. Contact Angle, Wettability and Adhesion 2008, 5:253-267. VSP/Brill, Leiden. K.L. Mittal (Ed.).
37. Posner R.G., Bold J., Bernstein Y., Rasor J., Braslow J., Hlavacek W.S., Perelson A.S. Measurement of receptor crosslinking at the cell surface via multiparameter flow cytometry. Advances in Optical Biophysics 1998, 3256:132-143.
38. Xu D., Young J.H., Krahn J.M., Song D., Corbett K.D., Chazin W.J., Pedersen L.C., Esko J.D. Stable RAGE-heparan sulfate complexes are essential for signal transduction. ACS Chem. Biol. 2013, 8:1611-1620.
39. Indurthi V.S., Leclerc E., Vetter S.W. Interaction between glycated serum albumin and AGE-receptors depends on structural changes and the glycation reagent. Arch. Biochem. Biophys. 2012, 528:185-196.
40. Yu L., Zhao Y., Xu S., Ding F., Jin C., Fu G., Weng S. Advanced glycation endproduct (AGE) - AGE receptor (RAGE) system upregulated connexin43 expression in rat cardiomyocytes via PKC and Erk MAPK pathways. Int. J. Mol. Sci. 2013, 14:2242-2257.
41. Rasheed Z., Aktar N., Haqqi T.M. Advanced glycation endproducts induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation endproduct-mediated activation of mitogen activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes. Rheumatology 2011, 50:838-851.
42. Shi L., Yu X., Yang H., Wu X. Advanced glycation endproducts induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and P38 MAPK. PLoS ONE 2013, 8:e66781.
43. Takino J., Yamagishi S., Takeuchi M. Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation endproducts. J. Oncol. 2010, 2010:739852.
44. Noh S., Jung J.J., Jung M., Kim K.H., Lee H.Y., Wang B., Cho J., Kim T.S., Jeung H.C., Rha S.Y. Body fluid MMP-2 as a putative biomarker in metastatic breast cancer. Oncol. Lett. 2012, 3:699-703.
45. Hallett M.A., Teng B., Hasegawa H., Schwab L.P., Seagroves T.N., Pourmotabbed T. Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer. Breast Cancer Res. 2013, 15:R12.
46. Zhang F., Banker G., Liu X., Suwanabol P.A., Lengfeld J., Yamanouchi D., Kent K.C., Liu B. The novel function of advanced glycation endproducts in regulation of MMP-9 production. J. Surg. Res. 2011, 171:871-876.
47. Sun C., Liang C., Ren Y., Zhen Y., He Z., Wang H., Tan H., Pan X., Wu Z. Advanced glycation endproducts depress function of endothelial progenitor cells via p38 and ERK1/2 mitogen-activated protein kinase pathways. Basic Res. Cardiol. 2009, 104:42-49.
48. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y., Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-kappa B, and by 17 beta-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 2000, 275:25781-25790.
49. Marsche G., Weigle B., Sattler W., Malle E. Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein. FASEB J. 2007, 21:3075-3082.
50. Zhou Q., Liu L.Z., Hu X., Shi X., Fang J., Jiang B.H. Reactive oxygen species regulate insulin-induced VEGF and HIF-1 alpha expression through activation of p70S6K1 in human prostate cancer cells. Carcinogenesis 2007, 28:28-37.
51. Dennis M.D., Jefferson L.S., Kimball S.R. Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of synthesis. J. Biol. Chem. 2012, 287:42890-42899.
52. Xu Q., Liu L.Z., Qian X., Chen Q., Jiang Y., Li D., Lai L., Jiang B.H. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res. 2012, 40:761-774.
53. Chung S.S., Aroh C., Vadgama J.V. Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells. PLoS ONE 2013, 8:e83971.
54. Wang X.F., Zhou Q.M., Du J., Zhang H., Lu Y.Y., Su S.B. Baicalin suppresses migration, invasion and metastasis of breast cancer via p38 MAPK signaling pathway. Anticancer Agents Med Chem. 2013, 13:923-931.
55. Ranaivo H.R., Hodge J.N., Choi N., Wainwright M.S. Albumin induces upregulation of matrix metalloproteinase-9 in astrocytes via MAPK and reactive oxygen species-dependent pathways. J. Neuroinflammation 2012, 9:68.
56. Kim H.M., Kim C.S., Lee J.H., Jang S.J., Hwang J.J., Ro S., Choi J. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells. PLoS ONE 2013, 8:e60383.
57. Sukhtankar D., Okun A., Chandramouli A., Nelson M.A., Vanderah T.W., Cress A.E., Porreca F., King T. Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Mol. Pain 2011, 7:81.